Skip NavigationSkip to Content

Single cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma

  1. Author:
    Zheng, Hongping
    Pomyen, Yotsawat
    Hernandez, Maria Olga
    Li, Caiyi
    Livak, Ferenc
    Tang, Wei
    Dang, Hien
    Greten, Tim F
    Davis, Jeremy
    Zhao, Yongmei
    Mehta, Monika
    Levin, Yelena
    Shetty, Jyoti
    Tran, Bao
    Budhu, Anuradha
    Wang, Xin Wei [ORCID]
  2. Author Address

    Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892., Translational Research Unit, Chulabhorn Research Institute, Bangkok, 10210, Thailand., Flow Cytometry Core Facility, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892., Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892., Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, 21701.,
    1. Year: 2018
    2. Date: Jul
    3. Epub Date: 2018 01 09
  1. Journal: Hepatology
    1. 68
    2. 1
    3. Pages: 127-140
  2. Type of Article: Article
  1. Abstract:

    Intratumor molecular heterogeneity of hepatocellular carcinoma (HCC) is partly attributed to the presence of hepatic cancer stem cells (CSCs). Different CSC populations defined by various cell surface markers may contain different oncogenic drivers, posing a challenge in defining molecular-targeted therapeutics. We combined transcriptomic and functional analyses of HCC cells at the single cell level to assess the degree of CSC heterogeneity. We provide evidence that hepatic CSCs at the single-cell level are phenotypically, functionally and transcriptionally heterogeneous. We found that different CSC subpopulations contain distinct molecular signatures. Interestingly, distinct genes within different CSC subpopulations are independently associated with HCC prognosis, suggesting that a diverse hepatic CSC transcriptome affects intratumor heterogeneity and tumor progression. Our work provides unique perspectives into the previously unappreciated diversity of CSC subpopulations, whose molecular heterogeneity further highlights their role in tumor heterogeneity, prognosis and hepatic CSC therapy. This article is protected by copyright. All rights reserved. © 2018 by the American Association for the Study of Liver Diseases.

    See More

External Sources

  1. DOI: 10.1002/hep.29778
  2. PMID: 29315726
  3. PMCID: PMC6033650
  4. WOS: 000437683600015

Library Notes

  1. Fiscal Year: FY2017-2018
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel